SOCS2 expression was significantly increased in patients with chronic myeloid leukemia (CML) in blast crisis as compared with chronic phase patients and healthy controls [46]. The gene discussed is SOCS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.